Dear Industry Partners,

EDITGENE Co., Ltd. is a globally recognized leader in biotechnology, specializing in innovative gene editing technologies. Our state-of-the-art facility focuses on CRISPR technologies, supporting applications in gene editing, cell biology, and antibody validation.

EDITGENE has independently developed four core platforms: the CRISPR-EDITx™ platform, the Bingo™ prime editing point mutation platform, the LION™ site-specific cell insertion platform, and the FASST rapid nucleic acid detection platform. These platforms enable comprehensive solutions, including CRISPR gene knockout/knockin, overexpression, endogenous point mutation, CRISPR library screening, nucleic acid detection, and custom development services. Our full range of gene editing products and services has successfully met the needs of researchers and institutions worldwide.

EDITGENE is dedicated to foundational technology research, engineering gene-editing enzymes based on three-dimensional structures and utilizing proprietary manufacturing processes to create enzyme formulations that outperform internationally recognized standards. Our innovations include:

● A gene knockout kit developed with novel transfection reagents, enabling seamless, non-toxic gene knockout in cells with efficiencies reaching 95%, even in challenging cell types like THP-1.

● The optimized Bingo™ point mutation platform, achieving editing efficiencies up to 85% in hard-to-transfect cells.

● The FASST rapid nucleic acid detection platform, delivering single-tube reactions with detection times of just 20 minutes and a sensitivity of 10 copies.

To date, EDITGENE has provided high-quality gene editing solutions and products to biological research institutes, life science laboratories, pharmaceutical companies, and CROs in over 50 countries worldwide.

As we expand our global business operations, we are actively seeking partnerships with distributors and collaborators across various regions. Through strategic collaboration, we aim to make our cutting-edge gene editing technologies and services more accessible to scientists and organizations worldwide.

We warmly invite interested partners to connect with us and explore opportunities to work together. Together, we can drive innovation and deliver transformative solutions to the global scientific community.

Sincerely,

EDITGENE Co., Ltd.